Alprostadil and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alprostadil (alprostadil) and Repaglinide (repaglinide). Common drug interactions include anaemia among females and blood urea increased among males.

The phase IV clinical study analyzes what interactions people have when they take Alprostadil and Repaglinide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Alprostadil?

Alprostadil has active ingredients of alprostadil. It is often used in erection problems. eHealthMe is studying from 2,653 Alprostadil users. Check the latest studies of Alprostadil.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

On Jul, 15, 2026

17 people who take Alprostadil and Repaglinide together, and have interactions are studied.

Alprostadil and Repaglinide drug interactions.

What are the common drug interactions of Alprostadil and Repaglinide, by gender? *:

female:

Anaemia (lack of blood)
Duodenal ulcer

male:

Blood urea increased
C-reactive protein increased
Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
White blood cell count increased
Impaired healing
Blood albumin decreased
Complications of transplanted kidney
Cough
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Kidney infection

What are the common drug interactions of Alprostadil and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Blood creatinine increased
Blood glucose increased
Blood triglycerides increased
Blood urea increased
C-reactive protein increased
Haemoglobin decreased
High density lipoprotein decreased
Incision site pain
Lymphocyte count decreased
Mouth ulceration (mouth ulcers)

40-49:

n/a

50-59:

Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Haemoglobin decreased
Incision site pain
Kidney infection
Lymphocyte count decreased
Pyrexia (fever)
Nasopharyngitis (inflammation of the nasopharynx)
Hypoproteinaemia (too little prolactin circulating in the blood)
Drug hypersensitivity
Erythema of eyelid (redness of the eyelid)

60+:

Pemphigoid (tense blisters on the skin)
Anaemia (lack of blood)
Duodenal ulcer
Amputation
Blood creatine phosphokinase increased
Genital candidiasis (candidiasis (fungus)infection of genital)

What are the existing conditions these people have? *

Blood Uric Acid Increased: 9 people, 52.94%
Blood Glucose Abnormal: 6 people, 35.29%
Drug Level Decreased: 5 people, 29.41%
Type 2 Diabetes: 5 people, 29.41%
Cardiovascular Insufficiency (inadequate functioning of heart): 5 people, 29.41%
High Blood Pressure: 5 people, 29.41%
Bone Marrow Failure: 5 people, 29.41%
Urination - Excessive Volume: 5 people, 29.41%
Pain: 5 people, 29.41%
Promotion Of Peripheral Circulation: 5 people, 29.41%

* Approximation only. Some reports may have incomplete information.

Do you take Alprostadil and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously